Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer

Scientific Reports
Hee Seung LeeSi Young Song

Abstract

Carbohydrate antigen (CA) 19-9 is the only diagnostic marker used in pancreatic cancer despite its limitations. Here, we aimed to identify the diagnostic role of CEMIP (also called KIAA1199) combined with CA 19-9 in patients with pancreatic cancer. A retrospective analysis of prospectively collected patient samples was performed to determine the benefit of diagnostic markers in the diagnosis of pancreatic cancer. We investigated CEMIP and CA 19-9 levels in 324 patients with pancreatic cancer and 49 normal controls using serum enzyme-linked immunosorbent assay. Median CA 19-9 and CEMIP levels were 410.5 U/ml (40.8-3342.5) and 0.67 ng/ml (0.40-1.08), respectively, in patients with pancreatic cancer. The AUROC for CA 19-9 and CEMIP were 0.847 (95% confidence interval [CI]: 0.806-0.888) and 0.760 (95% CI: 0.689-0.831), respectively. Combination of CA 19-9 with CEMIP showed markedly improved AUROC over CA 19-9 alone in pancreatic cancer diagnosis (0.94 vs. 0.89; P < 0.0001). CEMIP showed a diagnostic yield of 86.1% (68/79) in CA 19-9 negative pancreatic cancer. Combined use with CEMIP showed significantly improved diagnostic value compared with CA 19-9 alone in pancreatic cancer. Especially, CEMIP may be a complementary marker in pa...Continue Reading

Associated Clinical Trials

References

May 1, 1989·Annals of Internal Medicine·D K PleskowD K Podolsky
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
May 26, 2007·The Journal of Biological Chemistry·Fang WeiMichael L Atchison
Sep 9, 2008·Trends in Molecular Medicine·Thomas KlonischMarek Los
May 13, 2009·Annals of Surgical Oncology·Shinji MatsuzakiMasaki Mori
Aug 19, 2009·Nature Reviews. Clinical Oncology·Gregory SergeantBaki Topal
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Mar 10, 2011·Nature Medicine·Hans Clevers
Jul 26, 2011·Pancreas·Dawoon E JungSi Young Song
Feb 22, 2012·Gastroenterology Clinics of North America·Eun Ji Shin, Marcia Irene Canto
Nov 9, 2012·Gut·Marcia Irene CantoUNKNOWN International Cancer of Pancreas Screening (CAPS) Consortium
Dec 4, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mitsuro KandaMichael Goggins
May 24, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ang LiMichael Goggins
Aug 31, 2013·Journal of the National Cancer Institute·Nikki A EvensenJian Cao
Sep 26, 2013·Nature Reviews. Cancer·Benjamin Beck, Cédric Blanpain
Jan 23, 2014·JAMA : the Journal of the American Medical Association·Nicolai A SchultzJulia S Johansen
Sep 11, 2014·The New England Journal of Medicine·David P RyanNabeel Bardeesy
May 2, 2015·Pancreas·Suresh T ChariDavid Wong
Jul 1, 2015·Nature Reviews. Gastroenterology & Hepatology·Marcia I Canto, Ralph H Hruban
Dec 26, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Atsuhiro KogaKeiji Hirata
Mar 8, 2017·Annals of Surgery·Guopei LuoXianjun Yu

❮ Previous
Next ❯

Citations

Sep 7, 2018·Canadian Journal of Gastroenterology & Hepatology·Lumir KunovskyJan Trna
Mar 28, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jingmei LiuDean Tian
Mar 30, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fan ShenYang Zhao

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
ELISAs
pancreatectomy

Software Mentioned

SPSS
MedCalc
R
SAS
CEMIP
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.